Back
NovoCure Vs. Sage Therapeutics Industry Stock Comparison
Sell
47
NVCR
NovoCure
Last Price:
15.12
Seasonality Move:
6.82%
Sell
30
SAGE
Sage Therapeutics
Last Price:
13.90
Seasonality Move:
1%
Sell
47
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $14.78. The Score for NVCR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy, Sell or Hold?
- The current Sage Therapeutics [SAGE] share price is $13.94. The Score for SAGE is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- SAGE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVCR Stock Price Chart
SAGE Stock Price Chart
What is Sage Therapeutics's stock price today?
-
The Sage Therapeutics share price today is $13.94
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 61.74 | Buy |
| Chaikin Money Flow: | -175369 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.21 - 14.43) | Buy |
| Bollinger Bands (100): | (12.95 - 15.47) | Buy |
SAGE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.25 | Sell |
| Relative Strength Index (14 RSI): | 40.02 | Sell |
| Chaikin Money Flow: | 792027 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.25 - 16.55) | Sell |
| Bollinger Bands (100): | (16.7 - 24.88) | Sell |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.99 | Buy |
| 20-day SMA: | 13.03 | Buy |
| 50-day SMA: | 14.19 | Buy |
| 200-day SMA: | 17.01 | Sell |
| 8-day EMA: | 13.31 | Buy |
| 20-day EMA: | 13.21 | Buy |
| 50-day EMA: | 13.76 | Buy |
| 200-day EMA: | 22.18 | Sell |
SAGE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.71 | Buy |
| 20-day SMA: | 14.35 | Sell |
| 50-day SMA: | 17.76 | Sell |
| 200-day SMA: | 21.42 | Sell |
| 8-day EMA: | 13.69 | Buy |
| 20-day EMA: | 14.58 | Sell |
| 50-day EMA: | 17.09 | Sell |
| 200-day EMA: | 23.58 | Sell |
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and a decrease next year of $0.16 per share.
Sage Therapeutics Earnings Growth & SAGE Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.11 per share, a decrease next quarter of $0.15 per share, an increase this year of $3.05 per share, and an increase next year of $1.02 per share.
NovoCure Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sage Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||